The Patent Finder

Sangart, Inc.

Also on record
Records under this name other than the patents Sangart, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 5 patents it holds.

Back to Sangart, Inc.

PatentTitleStatus Expires Confidence
US 10,821,158Polyalkylene oxide valerate hemoglobin conjugates
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,029,001Diaspirin Crosslinked Pegylated Hemoglobin
Formerly held
Lapsed on the fee record
Ended Jul 24, 2026 · High confidence
Lapsed on the fee recordEnded Jul 24, 2026High confidence
US 11,359,004Succinimide-activated nitroxyl compounds and methods for the use thereof for nitroxylation of proteins
Formerly held
Lapsed on the fee record
Ended Jun 14, 2026 · From the USPTO record
Lapsed on the fee recordEnded Jun 14, 2026From the USPTO record
US 7,622,439Method to enhance hemodynamic stability using oxygen carrying compositions
Term ended
Term ended Aug 31, 2025 · From the USPTO record
Term endedTerm ended Aug 31, 2025From the USPTO record
US 8,278,275Method to enhance hemodynamic stability using oxygen carrying compositions
Lapsed on the fee record
Ended Oct 2, 2024 · From the USPTO record
Lapsed on the fee recordEnded Oct 2, 2024From the USPTO record
US 7,271,145Methods and compositions for oxygen transport comprising modified hemoglobin in plasma
Term ended
Term ended Nov 5, 2023 · From the USPTO record
Term endedTerm ended Nov 5, 2023From the USPTO record
US 9,138,464MalPEG Hb conjugate-containing compositions for delivering nitric oxide (NO) to cells
Lapsed on the fee record
Ended Sep 22, 2023 · From the USPTO record
Lapsed on the fee recordEnded Sep 22, 2023From the USPTO record
US 8,021,858Method for making polyalkylene oxide modified hemoglobin
Lapsed on the fee record
Ended Sep 20, 2023 · From the USPTO record
Lapsed on the fee recordEnded Sep 20, 2023From the USPTO record
US 6,974,795Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin
Term ended
Term ended Sep 11, 2022 · From the USPTO record
Term endedTerm ended Sep 11, 2022From the USPTO record
US 7,625,862Method for making a high oxygen affinity modified hemoglobin for oxygen transport
Term ended
Term ended Aug 27, 2022 · From the USPTO record
Term endedTerm ended Aug 27, 2022From the USPTO record
10 of 15 patents shown.
Pro members see all 15.
Pro members: see all 15 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited